Nuveen, LLC Tango Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 202,183 shares of TNGX stock, worth $287,099. This represents 0.0% of its overall portfolio holdings.
Number of Shares
202,183Holding current value
$287,099% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
126Shares Held
91MCall Options Held
1.4KPut Options Held
4.4K-
Trv Gp Iv, LLC Boston, MA16.9MShares$23.9 Million88.92% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$15.2 Million5.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$15.1 Million1.53% of portfolio
-
Nextech Invest Ag5.53MShares$7.86 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4MShares$5.68 Million0.07% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $125M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...